RK-4 Intracalvariosseous Injection

· Fuzhou Neurodawn Rongkang Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RK-4 Intracalvariosseous Injection, covering 2025-10-02 to 2025-10-02. Get the full timeline:

Most recent: Clinical Trial Update: RK-4 Intracalvariosseous Injection in Treatment of Acute Large Hemispheric Infarction [Phase 2]